CN102692502B - 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 - Google Patents
一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN102692502B CN102692502B CN201210125222.7A CN201210125222A CN102692502B CN 102692502 B CN102692502 B CN 102692502B CN 201210125222 A CN201210125222 A CN 201210125222A CN 102692502 B CN102692502 B CN 102692502B
- Authority
- CN
- China
- Prior art keywords
- quality control
- preparation
- pad
- kit
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 24
- 241000709721 Hepatovirus A Species 0.000 title abstract description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000003908 quality control method Methods 0.000 claims abstract description 30
- 239000010931 gold Substances 0.000 claims abstract description 20
- 229910052737 gold Inorganic materials 0.000 claims abstract description 20
- 239000000427 antigen Substances 0.000 claims abstract description 15
- 102000036639 antigens Human genes 0.000 claims abstract description 15
- 108091007433 antigens Proteins 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 14
- 241000700605 Viruses Species 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 238000012360 testing method Methods 0.000 claims description 41
- 238000001035 drying Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 239000004033 plastic Substances 0.000 claims description 11
- 229920003023 plastic Polymers 0.000 claims description 11
- 239000000020 Nitrocellulose Substances 0.000 claims description 6
- 229920001220 nitrocellulos Polymers 0.000 claims description 6
- 238000005204 segregation Methods 0.000 claims description 6
- 239000005030 aluminium foil Substances 0.000 claims description 5
- 241001494479 Pecora Species 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 239000002274 desiccant Substances 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000003319 supportive effect Effects 0.000 abstract description 4
- 238000003556 assay Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 48
- 210000002966 serum Anatomy 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 15
- 208000005252 hepatitis A Diseases 0.000 description 14
- 238000001556 precipitation Methods 0.000 description 13
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 10
- 239000003086 colorant Substances 0.000 description 9
- 239000012925 reference material Substances 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 8
- 206010019799 Hepatitis viral Diseases 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 201000001862 viral hepatitis Diseases 0.000 description 7
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000013019 agitation Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003365 glass fiber Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 208000002672 hepatitis B Diseases 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229920004934 Dacron® Polymers 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 229920006267 polyester film Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008293 association colloid Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000007449 liver function test Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
L1 | L2 | L3 | L4 | |
20090610 | + | + | ± | - |
20090620 | + | + | ± | - |
20090630 | + | + | ± | - |
标本类别 | 总份数 | 阴性份数 | 非特异反应率 |
丙肝抗体阳性 | 32 | 32 | 0% |
乙肝表面抗体阳性 | 64 | 64 | 0% |
戊肝IgM抗体阳性 | 31 | 31 | 0% |
乙肝核心抗体IgM阳性 | 10 | 10 | 0% |
标本类别 | 总份数 | 阴性份数 | 非特异反应率 |
丙肝抗体阳性 | 32 | 32 | 0% |
乙肝表面抗体阳性 | 64 | 64 | 0% |
戊肝IgM抗体阳性 | 31 | 31 | 0% |
乙肝核心抗体IgM阳性 | 10 | 10 | 0% |
标本类别 | 总份数 | 阴性份数 | 非特异反应率 |
丙肝抗体阳性 | 32 | 32 | 0% |
乙肝表面抗体阳性 | 64 | 64 | 0% |
戊肝IgM抗体阳性 | 31 | 31 | 0% |
乙肝核心抗体IgM阳性 | 10 | 10 | 0% |
添加浓度(mg/ml) | 0 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 12 |
10份阴性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
10份阳性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
L1 | + | + | + | + | + | + | + | + |
L2 | + | + | + | + | + | + | ± | - |
L3 | ± | ± | ± | ± | ± | ± | - | - |
L4 | - | - | - | - | - | - | - | - |
添加浓度(mg/l) | 0 | 30 | 75 | 150 | 300 |
10份阴性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
10份阳性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
L1 | + | + | + | + | + |
L2 | + | + | + | + | + |
L3 | ± | ± | ± | ± | ± |
L4 | - | - | - | - | - |
添加浓度(mg/ml) | 0 | 2 | 4 | 6 | 8 | 10 |
10份阴性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
10份阳性 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 | 10/10 |
L1 | + | + | + | + | + | + |
L2 | + | + | + | + | + | + |
L3 | ± | ± | ± | ± | ± | ± |
L4 | - | - | - | - | - | - |
序号 | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
高血脂病人血清加入量ml | 0 | 0.4 | 1.5 | 2 | 3 | 3.5 | 4 |
正常人血清加入量ml | 4 | 4 | 3 | 2 | 1.5 | 1 | 0 |
混合后甘油三酯浓度mmol/l | 0.72 | 1.34 | 3.01 | 4.16 | 5.31 | 6.07 | 7.6 |
甘油三酯浓度(mmol/l) | 0.72 | 1.34 | 3.01 | 4.16 | 5.31 | 6.07 | 7.6 |
正常人样本 | - | - | - | - | - | - | - |
强阳性样本 | + | + | + | + | + | + | + |
弱阳性样本 | ± | ± | ± | ± | ± | ± | ± |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210125222.7A CN102692502B (zh) | 2012-04-26 | 2012-04-26 | 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210125222.7A CN102692502B (zh) | 2012-04-26 | 2012-04-26 | 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102692502A CN102692502A (zh) | 2012-09-26 |
CN102692502B true CN102692502B (zh) | 2015-02-04 |
Family
ID=46858097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210125222.7A Expired - Fee Related CN102692502B (zh) | 2012-04-26 | 2012-04-26 | 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102692502B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103336119B (zh) * | 2013-06-27 | 2015-07-29 | 潍坊市康华生物技术有限公司 | 甲型肝炎病毒抗体胶体金检测盒 |
CN103364561A (zh) * | 2013-07-29 | 2013-10-23 | 武汉中博生物股份有限公司 | 猪圆环病毒2型抗体胶体金免疫层析检测试纸及制备方法 |
CN104330569B (zh) * | 2014-10-29 | 2016-08-24 | 武汉生命科技股份有限公司 | 一种快速检测抗体的试纸条 |
CN110672850A (zh) * | 2019-10-31 | 2020-01-10 | 迪瑞医疗科技股份有限公司 | 甲型肝炎病毒抗体IgM检测试剂盒及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005064340A3 (fr) * | 2003-12-24 | 2005-11-24 | Inodiag | Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles |
CN1746675A (zh) * | 2004-09-07 | 2006-03-15 | 李人 | 免疫层析测试条及其制造方法 |
CN101533025A (zh) * | 2008-03-14 | 2009-09-16 | 北京科美东雅生物技术有限公司 | 甲型肝炎病毒IgM抗体化学发光免疫测定试剂盒及其制备方法 |
CN201965131U (zh) * | 2010-12-17 | 2011-09-07 | 天津中新科炬生物制药有限公司 | 一种甲型肝炎病毒IgM抗体快速检测试纸 |
CN102288758A (zh) * | 2011-07-29 | 2011-12-21 | 北京中检安泰诊断科技有限公司 | 一种甲型肝炎病毒IgM抗体胶体金法检测试剂盒及其制备方法 |
WO2012019108A1 (en) * | 2010-08-05 | 2012-02-09 | Abbott Point Of Care Inc. | Magnetic immunosensor with trench configuration and method of use |
CN202149901U (zh) * | 2011-06-03 | 2012-02-22 | 正元盛邦(天津)生物科技有限公司 | 甲型肝炎病毒IgM和IgG抗体联合检测试纸 |
-
2012
- 2012-04-26 CN CN201210125222.7A patent/CN102692502B/zh not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005064340A3 (fr) * | 2003-12-24 | 2005-11-24 | Inodiag | Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles |
CN1746675A (zh) * | 2004-09-07 | 2006-03-15 | 李人 | 免疫层析测试条及其制造方法 |
CN101533025A (zh) * | 2008-03-14 | 2009-09-16 | 北京科美东雅生物技术有限公司 | 甲型肝炎病毒IgM抗体化学发光免疫测定试剂盒及其制备方法 |
WO2012019108A1 (en) * | 2010-08-05 | 2012-02-09 | Abbott Point Of Care Inc. | Magnetic immunosensor with trench configuration and method of use |
CN201965131U (zh) * | 2010-12-17 | 2011-09-07 | 天津中新科炬生物制药有限公司 | 一种甲型肝炎病毒IgM抗体快速检测试纸 |
CN202149901U (zh) * | 2011-06-03 | 2012-02-22 | 正元盛邦(天津)生物科技有限公司 | 甲型肝炎病毒IgM和IgG抗体联合检测试纸 |
CN102288758A (zh) * | 2011-07-29 | 2011-12-21 | 北京中检安泰诊断科技有限公司 | 一种甲型肝炎病毒IgM抗体胶体金法检测试剂盒及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102692502A (zh) | 2012-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100492010C (zh) | 生物传感器 | |
JP3553045B2 (ja) | バイオセンサ | |
CN101140284A (zh) | 一种结核分枝杆菌抗体快速诊断试剂盒及其检测方法 | |
HUT73379A (en) | Chromatographic assay device for detection or determination of an analyte in a sample | |
CN105092861A (zh) | 一种crp/saa定量联合检测免疫荧光层析试纸及其制备方法 | |
CN101852800B (zh) | 半定量检测人全血中他克莫司药物浓度的胶体金试纸条及检测方法 | |
CN204142734U (zh) | 新型免疫层析试纸条 | |
CN102692502B (zh) | 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 | |
JPH06508215A (ja) | 検定装置 | |
CN101738475B (zh) | 戊型肝炎病毒抗体检测试剂盒及其制备方法 | |
CN202916285U (zh) | 一种全血免疫层析装置 | |
CN204964521U (zh) | 一种crp/saa定量联合检测免疫荧光层析试纸 | |
CN102109519A (zh) | 风疹病毒IgG、IgM抗体联检试剂盒及其制备方法 | |
CN106546750A (zh) | 一种微量白蛋白快速定量检测试纸条的制备及检测方法 | |
CN101173924A (zh) | 生物液体样本检测卡 | |
JP4223163B2 (ja) | 免疫クロマトグラフィー試験片、及びクロマトグラフ分析方法 | |
CN111596064A (zh) | 同时检测pedv和tgev的速测卡及其制备、使用方法 | |
CN114034858A (zh) | 一种检测新冠疫苗注射后体内中和抗体的胶体金免疫层析试纸条及其制备方法 | |
CN106596968A (zh) | 一种检测尿微量白蛋白斑点金渗滤试剂盒及其应用 | |
JP4115728B2 (ja) | フロースルー式検査法用組成物、これを用いたキット及び検査法 | |
US20090263905A1 (en) | Detection test assembly for detecting the presence of a substance in a sample | |
CN101738476B (zh) | 乙肝病毒前s1抗原快速诊断试剂盒及其制备方法 | |
CN103336119B (zh) | 甲型肝炎病毒抗体胶体金检测盒 | |
CN101738474A (zh) | 一种巨细胞病毒、风疹病毒联合检测试剂检测卡 | |
CN110261597A (zh) | 一种ia-2自身抗体检测试条 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100076 Beijing city Fengtai District pan Temple No. 20 Patentee after: BEIJING NORTH INSTITUTE OF BIOLOGICAL TECHNOLOGY Address before: 100076 Beijing city Fengtai District pan Temple No. 20 Patentee before: Beijing North Institute of Biological Technology |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210802 Address after: 200000 Room 201, building 1, No. 1666, Xinyang Road, Lingang xinpian District, China (Shanghai) pilot Free Trade Zone, Shanghai Patentee after: SHANGHAI EUGENE BIOTECH Co.,Ltd. Address before: 20 panjiamiao, Fengtai District, Beijing 100076 Patentee before: BEIJING NORTH INSTITUTE OF BIOLOGICAL TECHNOLOGY |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150204 |